NAV on (No Data Available)
₹0.00
No Data Available
Fund Size
₹262.84 Crores
1Y Returns
No Data Available%
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Launch Date
October 18, 2021
Fund Manager
Mr. Animesh Singh
Initial Price
10
AUM Fund
262.84 Cr
Min investment
Rs 5000
Expense Ratio
0.98%
"Daily - Rs. 500/- and in multiples of Re. 1/- thereafter. Minimum 30 Instalments. Weekly - Rs. 500/- and in multiples of Re. 1/- thereafter. Minimum 12 installments.Weekly - Rs. 1000/- and in multiples of Re. 1/- thereafter. Minimum 6 installments.Monthly - Rs. 500/- and in multiples of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 1000/- and in multiples of Re. 1/- thereafter. Minimum 6 installments."
"If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil."
| Equity / Mid Cap funds | 1Y | 3Y | Fund Size (Cr) |
|---|---|---|---|
| 25.04% | 0.00% | ₹2939.98 | |
| 25.04% | 0.00% | ₹2939.98 | |
| 24.51% | 0.00% | ₹682.39 | |
| 24.50% | 0.00% | ₹682.39 | |
| 24.01% | 0.00% | ₹111.64 |
Q: What is the current NAV of ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment?
A: The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment is ₹ .
Q: What type of mutual fund is ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment?
A: ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment is a 'Equity - Pharma' type mutual fund managed by 'ITI Asset Management Limited'.
Q: What is the expense ratio of ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment?
A: The expense ratio of ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment is 0.98%, which impacts overall returns.
Q: Who manages ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment?
A: ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment is managed by Mr. Animesh Singh, who oversees investment strategy and portfolio decisions.
Q: Is ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment a good investment?
A: ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment may be suitable depending on your financial goals, risk appetite, and investment horizon. Always evaluate fund performance and consult a financial advisor.
Q: What is the exit load of ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment?
A: The exit load of ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment is "If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.", applicable if redeemed within the specified period.
Q: How is ITI Pharma and Healthcare Fund - Direct Plan - IDCW-Reinvestment taxed?
A: Taxation depends on the fund type (equity/debt) and holding period as per Indian tax laws.
